MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study
- 1 May 2005
- journal article
- other
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 91 (1) , 73-79
- https://doi.org/10.1007/s10549-004-7265-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemiaThe Pharmacogenomics Journal, 2003
- Thymidylate synthase inhibitors as anticancer agents: from bench to bedsideCancer Chemotherapy and Pharmacology, 2003
- Effect of methylenetetrahydrofolate reductase 677C→T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patientsInternational Journal of Cancer, 2002
- The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteineAtherosclerosis, 2001
- Mthfr (C677T) polymorphisms and stage III colon cancer: Response to therapyMolecular Diagnosis, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Modulation of methylenetetrahydrofolate reductase activity by S-adenosylmethionine and by dihydrofolate and its polyglutamate analoguesAdvances in Enzyme Regulation, 1982